BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36162994)

  • 1. MediQuit - an electronic deprescribing tool: a pilot study in German primary care; GPs' and patients' perspectives.
    Michiels-Corsten M; Gerlach N; Junius-Walker U; Schleef T; Donner-Banzhoff N; Viniol A
    BMC Prim Care; 2022 Sep; 23(1):252. PubMed ID: 36162994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General Practice.
    Junius-Walker U; Viniol A; Michiels-Corsten M; Gerlach N; Donner-Banzhoff N; Schleef T
    Drugs Aging; 2021 Aug; 38(8):725-733. PubMed ID: 34251594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.
    Jungo KT; Mantelli S; Rozsnyai Z; Missiou A; Kitanovska BG; Weltermann B; Mallen C; Collins C; Bonfim D; Kurpas D; Petrazzuoli F; Dumitra G; Thulesius H; Lingner H; Johansen KL; Wallis K; Hoffmann K; Peremans L; Pilv L; Šter MP; Bleckwenn M; Sattler M; van der Ploeg M; Torzsa P; Kánská PB; Vinker S; Assenova R; Bravo RG; Viegas RPA; Tsopra R; Pestic SK; Gintere S; Koskela TH; Lazic V; Tkachenko V; Reeve E; Luymes C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2021 Jan; 21(1):19. PubMed ID: 33413142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial.
    Jungo KT; Meier R; Valeri F; Schwab N; Schneider C; Reeve E; Spruit M; Schwenkglenks M; Rodondi N; Streit S
    BMC Fam Pract; 2021 Jun; 22(1):123. PubMed ID: 34157981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
    Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
    Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a deprescribing tool on the use of sedative hypnotics among older patients: study protocol for a cluster randomised controlled trial in Swiss primary care (the HYPE trial).
    Weiss K; Pichierri G; Grischott T; Groth S; Neuner-Jehle S
    BMJ Open; 2023 Sep; 13(9):e075828. PubMed ID: 37730388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPs' mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice.
    Kuberska K; Scheibl F; Sinnott C; Sheppard JP; Lown M; Williams M; Payne RA; Mant J; McManus RJ; Burt J
    Br J Gen Pract; 2021 Jul; 71(708):e498-e507. PubMed ID: 34001537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
    Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
    Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deprescribing in older patients by early-career general practitioners: Prevalence and associations.
    Magin P; Quain D; Tapley A; van Driel M; Davey A; Holliday E; Ball J; Kaniah A; Turner R; Spike N; FitzGerald K; Hilmer S
    Int J Clin Pract; 2021 Aug; 75(8):e14325. PubMed ID: 33960089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia.
    Gillespie R; Mullan J; Harrison L
    Health Soc Care Community; 2022 Nov; 30(6):e6206-e6216. PubMed ID: 36165345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.
    Zechmann S; Trueb C; Valeri F; Streit S; Senn O; Neuner-Jehle S
    BMC Fam Pract; 2019 May; 20(1):64. PubMed ID: 31088397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of inappropriate medication in older populations by electronic decision support (the PRIMA-eDS study): a qualitative study of practical implementation in primary care.
    Rieckert A; Sommerauer C; Krumeich A; Sönnichsen A
    BMC Fam Pract; 2018 Jul; 19(1):110. PubMed ID: 29986668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacist integrated into a general practice in Australia: an evolving model of care in medicines optimization.
    Jordan M; Mullan J; Stewart A; Chen TF
    Int J Pharm Pract; 2023 Dec; 31(6):608-616. PubMed ID: 37823732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Older Adult Health Literacy in the Day-to-Day Management of Polypharmacy and Making Decisions About Deprescribing: A Mixed Methods Study.
    Gillespie R; Mullan J; Harrison L
    Health Lit Res Pract; 2023 Jan; 7(1):e14-e25. PubMed ID: 36629783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing for older adults in Australia: factors influencing GPs.
    Gillespie R; Mullan J; Harrison L
    Aust J Prim Health; 2018 Jan; 24(6):463-469. PubMed ID: 30423283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supporting conversations about medicines and deprescribing: GPs' perspectives on a Medicines Conversation Guide.
    Weir KR; Bonner C; Naganathan V; Tam CWM; Rigby D; McLachlan AJ; Jansen J
    Int J Pharm Pract; 2023 Mar; 31(1):102-105. PubMed ID: 36413580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    Int J Clin Pract; 2016 Mar; 70(3):261-76. PubMed ID: 26918508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.